著者

小久江 伸介 大野 能之 折山 豊仁 山口 諒 徳田 篤志 長瀬 幸恵 鈴木 洋史

出版者

一般社団法人日本医療薬学会

雑誌

医療薬学 (ISSN:1346342X)

巻号頁・発行日

vol.42, no.10, pp.694-700, 2016-10-10 (Released:2017-10-10)

参考文献数

7

被引用文献数

1 4

---

At the University of Tokyo hospital, we began allocation of ward pharmacists to some wards in August 2012 and to all wards in August 2014. In this study, we qualitatively and quantitatively reviewed cases reported by ward pharmacists to evaluate the effects of this allocation on intervention and consultation that required positive participation.We retrospectively reviewed the pharmaceutical interventions' record from April 2012 through March 2015. We also analyzed cases for three months after the allocation of pharmacists to every ward. We found a highly positive correlation (R2 = 0.928, P < 0.0001) between the number of wards and pharmaceutical interventions. Intervention cases per month increased by 21.5 after allocating a pharmacist to a ward. There were a total of 2,438 intervention cases over three months. Active and passive approaches were employed in 1,833 cases and 605 cases, respectively. High-risk medicines were associated with 39.3% of cases. The prescription change rate was 86.2% for active interventions and 50.9% for passive interventions.Results showed that the allocation of a ward pharmacist could assist pharmaceutical approaches through the evaluation of patient complaints and clinical conditions, participation in the treatment plan, and consultation from medical staff. There were also reports that an active approach led to critical adverse event avoidance and pharmacotherapy effect improvement. These findings suggest that the allocation of ward pharmacists results in the promotion of healthcare services and medical safety.

著者

関根 祐子 木津 純子 長瀬 幸恵 荒川 基記 安野 伸浩 遠藤 睦 柳 真志帆 山中 緑 大山 実 荒川 義弘

出版者

一般社団法人 日本医療薬学会

雑誌

病院薬学 (ISSN:03899098)

巻号頁・発行日

vol.26, no.1, pp.61-68, 2000 (Released:2011-08-11)

参考文献数

11

被引用文献数

1

---

To determine whether the cotreatment with histamine H1 antagonists (H1) and histamine H2 antagonists (H2) are effective in treating chronic urticaria sufferers whose condition does not improve by H1 antagonist alone, we investigated academic books, papers provided by pharmaceutical companies and the MEDLINE on-line data base. No sufficient information could be found from inquiries of books and company-provided papers. However, from the MEDLINE data base, six papers on clinical trials based on the protocols of randomized controlled on trial were obtained and used as evidence. We also performed a meta-analysis based on the findings of the 6 papers.It is thus considered indispensable for drug information services to find appropriate papers using a data base search and then provide such information to doctors together with a critical appraisal by pharmacists.